Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Pryka

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|December 1, 1994
Vancomycin serum concentration monitoring: a continued debateR D Pryka
The Annals of Pharmacotherapy|September 1, 1994
Meropenem: a new carbapenem antimicrobialR D Pryka, G M Haig
Clinical Pharmacokinetics|April 1, 1991
An updated comparison of drug dosing methods. Part II: TheophyllineS M Erdman, K A Rodvold, R D Pryka
Clinical Pharmacokinetics|June 1, 1991
An updated comparison of drug dosing methods. Part IV: VancomycinR D Pryka, K A Rodvold, S M Erdman
Clinical Pharmacy|September 1, 1988
Teicoplanin: an investigational glycopeptide antibioticR D Pryka, K A Rodvold, J C Rotschafer
Clinical Pharmacokinetics|May 1, 1991
An updated comparison of drug dosing methods. Part III: Aminoglycoside antibioticsS M Erdman, K A Rodvold, R D Pryka
Clinical Pharmacokinetics|March 1, 1991
An updated comparison of drug dosing methods. Part I: PhenytoinR D Pryka, K A Rodvold, S M Erdman
Therapeutic Drug Monitoring|January 1, 1989
Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian modelsR D Pryka, K A Rodvold, M Garrison, et al.
Therapeutic Drug Monitoring|January 1, 1989
Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrationsK A Rodvold, R D Pryka, M Garrison, et al.
Clinical Pharmacokinetics|July 1, 1997
Pharmacokinetics and administration regimens of vancomycin in neonates, infants and childrenK A Rodvold, J A Everett, R D Pryka, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|December 1, 1994
Vancomycin serum concentration monitoring: a continued debateR D Pryka
The Annals of Pharmacotherapy|September 1, 1994
Meropenem: a new carbapenem antimicrobialR D Pryka, G M Haig
Clinical Pharmacokinetics|April 1, 1991
An updated comparison of drug dosing methods. Part II: TheophyllineS M Erdman, K A Rodvold, R D Pryka
Clinical Pharmacokinetics|June 1, 1991
An updated comparison of drug dosing methods. Part IV: VancomycinR D Pryka, K A Rodvold, S M Erdman
Clinical Pharmacy|September 1, 1988
Teicoplanin: an investigational glycopeptide antibioticR D Pryka, K A Rodvold, J C Rotschafer
Clinical Pharmacokinetics|May 1, 1991
An updated comparison of drug dosing methods. Part III: Aminoglycoside antibioticsS M Erdman, K A Rodvold, R D Pryka
Clinical Pharmacokinetics|March 1, 1991
An updated comparison of drug dosing methods. Part I: PhenytoinR D Pryka, K A Rodvold, S M Erdman
Therapeutic Drug Monitoring|January 1, 1989
Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian modelsR D Pryka, K A Rodvold, M Garrison, et al.
Therapeutic Drug Monitoring|January 1, 1989
Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrationsK A Rodvold, R D Pryka, M Garrison, et al.
Clinical Pharmacokinetics|July 1, 1997
Pharmacokinetics and administration regimens of vancomycin in neonates, infants and childrenK A Rodvold, J A Everett, R D Pryka, et al.
Pageof 2